These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

585 related items for PubMed ID: 29572094

  • 1. Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients.
    Turner AM, Stolk J, Bals R, Lickliter JD, Hamilton J, Christianson DR, Given BD, Burdon JG, Loomba R, Stoller JK, Teckman JH.
    J Hepatol; 2018 Aug; 69(2):378-384. PubMed ID: 29572094
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease.
    Wooddell CI, Blomenkamp K, Peterson RM, Subbotin VM, Schwabe C, Hamilton J, Chu Q, Christianson DR, Hegge JO, Kolbe J, Hamilton HL, Branca-Afrazi MF, Given BD, Lewis DL, Gane E, Kanner SB, Teckman JH.
    JCI Insight; 2020 Jun 18; 5(12):. PubMed ID: 32379724
    [Abstract] [Full Text] [Related]

  • 5. Association of circulating Z-polymer with adverse clinical outcomes and liver fibrosis in adults with alpha-1 antitrypsin deficiency.
    Fromme M, Rademacher L, Amzou S, Cook CD, Zacharias I, Zhang L, Ripollone JE, Strnad P.
    United European Gastroenterol J; 2024 Oct 18; 12(8):1091-1101. PubMed ID: 39024029
    [Abstract] [Full Text] [Related]

  • 6. Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation.
    Hamesch K, Mandorfer M, Pereira VM, Moeller LS, Pons M, Dolman GE, Reichert MC, Schneider CV, Woditsch V, Voss J, Lindhauer C, Fromme M, Spivak I, Guldiken N, Zhou B, Arslanow A, Schaefer B, Zoller H, Aigner E, Reiberger T, Wetzel M, Siegmund B, Simões C, Gaspar R, Maia L, Costa D, Bento-Miranda M, van Helden J, Yagmur E, Bzdok D, Stolk J, Gleiber W, Knipel V, Windisch W, Mahadeva R, Bals R, Koczulla R, Barrecheguren M, Miravitlles M, Janciauskiene S, Stickel F, Lammert F, Liberal R, Genesca J, Griffiths WJ, Trauner M, Krag A, Trautwein C, Strnad P, European Alpha1-Liver Study Group.
    Gastroenterology; 2019 Sep 18; 157(3):705-719.e18. PubMed ID: 31121167
    [Abstract] [Full Text] [Related]

  • 7. Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort.
    Clark VC, Marek G, Liu C, Collinsworth A, Shuster J, Kurtz T, Nolte J, Brantly M.
    J Hepatol; 2018 Dec 18; 69(6):1357-1364. PubMed ID: 30138687
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Quantitative Lipid Profiling Reveals Major Differences between Liver Organoids with Normal Pi*M and Deficient Pi*Z Variants of Alpha-1-antitrypsin.
    Pérez-Luz S, Lalchandani J, Matamala N, Barrero MJ, Gil-Martín S, Saz SR, Varona S, Monzón S, Cuesta I, Justo I, Marcacuzco A, Hierro L, Garfia C, Gomez-Mariano G, Janciauskiene S, Martínez-Delgado B.
    Int J Mol Sci; 2023 Aug 05; 24(15):. PubMed ID: 37569847
    [Abstract] [Full Text] [Related]

  • 11. Alpha-1 antitrypsin Null mutations and severity of emphysema.
    Fregonese L, Stolk J, Frants RR, Veldhuisen B.
    Respir Med; 2008 Jun 05; 102(6):876-84. PubMed ID: 18353624
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. RNAi therapeutics for diseases involving protein aggregation: fazirsiran for alpha-1 antitrypsin deficiency-associated liver disease.
    Strnad P, San Martin J.
    Expert Opin Investig Drugs; 2023 Jun 05; 32(7):571-581. PubMed ID: 37470509
    [Abstract] [Full Text] [Related]

  • 15. An association between plasma levels of α2-macroglobulin and α1-antitrypsin in PiMM and PiZZ individuals differing in COPD presentation.
    Lechowicz U, Martinez-Delgado B, Liu B, Wrenger S, Rozy A, Zdral A, DeLuca DS, Welte T, Janciauskiene S, Chorostowska-Wynimko J.
    Clin Biochem; 2024 Apr 05; 126():110736. PubMed ID: 38428450
    [Abstract] [Full Text] [Related]

  • 16. Alpha-1 antitrypsin deficiency: A re-surfacing adult liver disorder.
    Fromme M, Schneider CV, Trautwein C, Brunetti-Pierri N, Strnad P.
    J Hepatol; 2022 Apr 05; 76(4):946-958. PubMed ID: 34848258
    [Abstract] [Full Text] [Related]

  • 17. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.
    Green CE, Vayalapra S, Hampson JA, Mukherjee D, Stockley RA, Turner AM.
    Thorax; 2015 Oct 05; 70(10):939-45. PubMed ID: 26141072
    [Abstract] [Full Text] [Related]

  • 18. Hepatocyte proteomes reveal the role of protein disulfide isomerase 4 in alpha 1-antitrypsin deficiency.
    Karatas E, Raymond AA, Leon C, Dupuy JW, Di-Tommaso S, Senant N, Collardeau-Frachon S, Ruiz M, Lachaux A, Saltel F, Bouchecareilh M.
    JHEP Rep; 2021 Aug 05; 3(4):100297. PubMed ID: 34151245
    [Abstract] [Full Text] [Related]

  • 19. Outcomes for recipients of liver transplantation for alpha-1-antitrypsin deficiency–related cirrhosis.
    Carey EJ, Iyer VN, Nelson DR, Nguyen JH, Krowka MJ.
    Liver Transpl; 2013 Dec 05; 19(12):1370-6. PubMed ID: 24019185
    [Abstract] [Full Text] [Related]

  • 20. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
    Casas F, Blanco I, Martínez MT, Bustamante A, Miravitlles M, Cadenas S, Hernández JM, Lázaro L, Rodríguez E, Rodríguez-Frías F, Torres M, Lara B.
    Arch Bronconeumol; 2015 Apr 05; 51(4):185-92. PubMed ID: 25027067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.